Point72 Asia (Singapore) Pte. Ltd. Keros Therapeutics, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $532 Billion
- Q3 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 3,844 shares of KROS stock, worth $41,745. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,844
Previous 2,811
36.75%
Holding current value
$41,745
Previous $128 Million
73.78%
% of portfolio
0.04%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding KROS
# of Institutions
176Shares Held
30.1MCall Options Held
76.8KPut Options Held
9K-
Black Rock Inc. New York, NY2.51MShares$27.3 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY1.9MShares$20.6 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.86MShares$20.2 Million0.0% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.52MShares$16.5 Million7.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.51MShares$16.4 Million0.01% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $280M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...